Puli's New Product Debuts in the United States: Amiodarone Hydrochloride Injection Debuts for Export to the United States, Zhejiang Puli Achieves Zero Injection Export to the United States! Puli Pharmaceutical's amiodarone hydrochloride injection was first exported to Zhejiang Puli Pharmaceutical Co., Ltd. in the United States. The Pulidian and amiodarone hydrochloride injection produced by Puli Pharmaceutical Co., Ltd. received marketing authorization for amiodarone hydrochloride injection from the US Food and Drug Administration (FDA) in September two thousand twenty-four. Recently, the first batch of shipments to the United States have been completed, achieving a breakthrough of zero exports of Puli injections from Zhejiang to the United States! Approved in September, the first export of Puli products can be achieved in November. Puli people are drawing an international market blueprint for Puli products that are "suitable for sale" globally at an international speed! In September two thousand twenty-four, Puli Pharmaceutical's production of amiodarone hydrochloride injection was approved for marketing by the US Food and Drug Administration (FDA)! Puli Pharmaceutical's amiodarone hydrochloride injection is a product that has been approved by both China and the United States. It was approved for market by the National Medical Products Administration in China in November two thousand twenty-four, and its trade name is Pulidian Tong. Amiodarone hydrochloride injection is produced on the same production line both domestically and internationally, and is produced globally. It is an integrated variety of raw materials and formulations, directly supplying raw materials and ensuring stable clinical supply. At the same time, Puli Pharmaceutical sincerely welcomes Chinese raw material manufacturers to unite and go global, and cooperate with global formulation supply together! The first launch of Puli's amiodarone hydrochloride injection was completed in just two months from approval to launch, reflecting Puli's continuous self-improvement and timely satisfaction of the scarce demand in the US amiodarone hydrochloride injection market. It will have a positive impact on the company's expansion into the US market and achieve export earnings! The significant feature of Puli Pharmaceutical's products in the international market is that they are on the right market and are currently being registered on the pipeline. So far, Puli Pharmaceutical has obtained internationally registered varieties in Europe and America, and can quickly achieve export earnings after placing orders! two. Market data for amiodarone hydrochloride injection. Amiodarone hydrochloride is a multi ion channel blocker that has the effects of expanding the coronary artery, lowering blood pressure, improving heart function, and anti arrhythmic effects. It is used to treat arrhythmia and is a broad-spectrum antiarrhythmic drug. Amiodarone hydrochloride injection is an emergency rescue drug that has been used for many years. It is a clinically necessary and often in short supply drug, and is the first-line medication for anti arrhythmic treatment. According to IQVIA data, the global sales of amiodarone hydrochloride injections in two thousand twenty-three are approximately RMB eight hundred and ninety million, with a stable growth rate in recent years. The US market accounts for fifty-four% of the market share, making it the largest market in the world. The global market share data of amiodarone hydrochloride injection in two thousand twenty-three is sourced from IQVIA database. In recent years, the global market share of amiodarone hydrochloride injection in the United States has continued to grow. Specifically, in two thousand twenty-one, the US market accounted for fifty-one% of the global market share; By two thousand twenty-two, this proportion will increase to fifty-two%; Further increase to fifty-four% in the first half of two thousand twenty-three; By the first half of two thousand twenty-four, the global market share of the United States had reached fifty-six%, making it the largest market for amiodarone hydrochloride injection worldwide
